Literature DB >> 21321155

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

L Samuel Wann, Anne B Curtis, Kenneth A Ellenbogen, N A Mark Estes, Michael D Ezekowitz, Warren M Jackman, Craig T January, James E Lowe, Richard L Page, David J Slotwiner, William G Stevenson, Cynthia M Tracy, Valentin Fuster, Lars E Rydén, David S Cannom, Harry J Crijns, Anne B Curtis, Kenneth A Ellenbogen, Jonathan L Halperin, G Neal Kay, Jean-Yves Le Heuzey, James E Lowe, S Bertil Olsson, Eric N Prystowsky, Juan Luis Tamargo, L Samuel Wann, Alice K Jacobs, Jeffrey L Anderson, Nancy Albert, Mark A Creager, Steven M Ettinger, Robert A Guyton, Jonathan L Halperin, Judith S Hochman, Frederick G Kushner, Erik Magnus Ohman, William G Stevenson, Clyde W Yancy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21321155     DOI： 10.1161/CIR.0b013e31820f14c0

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  49 in total

1.  Fast atrial fibrillation and caecal volvulus--a case report and evidence based management.

Authors:  Alexander Liu; Edward Nicol
Journal:  BMJ Case Rep       Date:  2011-12-20

Review 2.  Promise of factor Xa inhibition in atrial fibrillation.

Authors:  Sana M Al-Khatib; John H Alexander; Renato D Lopes; Kenneth W Mahaffey; Manesh R Patel; Christopher B Granger
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

3.  Recommendations for stroke: 2010.

Authors:  Alexandre Ackaoui; Jean-Pierre Pellerin
Journal:  CMAJ       Date:  2011-10-04       Impact factor: 8.262

4.  Clinical and prognostic implications of atrial fibrillation in patients undergoing transcatheter aortic valve implantation.

Authors:  Pablo Salinas; Raúl Moreno; Luis Calvo; Santiago Jiménez-Valero; Guillermo Galeote; Angel Sánchez-Recalde; Teresa López-Fernández; Sergio Garcia-Blas; Diego Iglesias; Luis Riera; Isidro Moreno-Gómez; Jose María Mesa; Ignacio Plaza; Rocio Ayala; Rosa Gonzalez; José-Luis López-Sendón
Journal:  World J Cardiol       Date:  2012-01-26

Review 5.  Evidence behind quality of care measures for venous thromboembolism and atrial fibrillation.

Authors:  G Eymin; A K Jaffer
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

Review 6.  New oral anticoagulants in non-valvular atrial fibrillation.

Authors:  Pietro Francia; Carmen Adduci; Daria Santini; Beatrice Musumeci; Giuliano Tocci
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-05-08

7.  Review of the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial: warfarin versus dabigatran.

Authors:  Christopher Ingelmo; Oussama Wazni
Journal:  Curr Cardiol Rep       Date:  2011-10       Impact factor: 2.931

8.  LOWERING THE RISK FOR THROMBUS AND STROKE IN ATRIAL FIBRILLATION PATIENTS: Will Dabigatran Replace Warfarin?

Authors:  Alex Y Tan; Michael A Rosenberg
Journal:  Clin Med Rev Vasc Health       Date:  2013-06-20

9.  Novel anticoagulants in atrial fibrillation stroke prevention.

Authors:  Nicholas B Norgard; James J Dinicolantonio; Taylor J Topping; Benjamin Wee
Journal:  Ther Adv Chronic Dis       Date:  2012-05       Impact factor: 5.091

10.  Erratum: utilization of anticoagulation therapy in medicare patients with nonvalvular atrial fibrillation.

Authors:  Kate Fitch; Jonah Broulette; Bruce Pyenson; Kosuke Iwasaki; Winghan Jacqueline Kwong
Journal:  Am Health Drug Benefits       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.